XFG, a COVID-19 variant nicknamed "American COVID" or "Stratus," is circulating as health authorities report an increase in coronavirus activity, just as we head into the colder months. XFG remains the most common current COVID-19 variant in the United Kingdom, according to the UK Health Security Agency (UKHSA). The agency said on October 8 that positive COVID-19 test results increased to around 7 percent during September, while hospital admission rates increased by 50 percent.
UKHSA said that similar increases have been seen and reported across Europe and the United States. XFG is a COVID-19 variant that developed from a combination of two earlier variants, LF.7 and LP.8.1.2. The earliest known sample was collected on January 27, 2025, according to the World Health Organization (WHO).
The organization began monitoring XFG in June 2025, after it started spreading more widely around the world. The strain has also circulated extensively in the United States. Data previously published by the Centers for Disease Control and Prevention (CDC) identified the related XFG.1.1 lineage as the predominant variant in U.S. wastewater surveillance.
There isn’t any official evidence that XFG triggers a completely different set of symptoms from other recent COVID-19 variants. However, a common symptom, alongside the familiar symptoms, which include a sore throat, cough, and a fever, seems to be a hoarse or croaky voice. Kaywaan Khan, Harley Street physician and founder of Hannah London Clinic, told Cosmopolitan UK last year: "One of the most noticeable symptoms of the Stratus variant is hoarseness, which includes a scratchy or raspy voice.' The key distinction is that doctors can’t tell whether someone has the XFG variant from their symptoms alone.
Instead, the CDC says that scientists are using genetic sequencing, which looks at the genetic makeup of the virus, to distinguish it from other COVID variants. In its initial assessment, WHO rated the global public-health risk from XFG as low. The organization said there was no evidence it caused more severe illness or deaths than other circulating variants.
It added that approved COVID-19 vaccines were expected to remain effective against XFG. UKHSA reached a similar conclusion. Despite the recent increase in hospitalizations, it said hospital admissions have been rising in line with the overall increase in COVID circulation rather than disproportionately.
Extract — continue reading at the source.
